Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2014

Published: Apr-2014 | Format: PDF | GlobalData | Number of pages: 120 | Code: MRS - 24037


GlobalData''s clinical trial report, Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2014" provides data on the Subependymal Giant Cell Astrocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Subependymal Giant Cell Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Subependymal Giant Cell Astrocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData''s team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 3
List of Figures 4

Introduction 5
Subependymal Giant Cell Astrocytoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Subependymal Giant Cell Astrocytoma 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Prominent Drugs 24
Latest Clinical Trials News on Subependymal Giant Cell Astrocytoma 25
Nov 13, 2012: Everolimus Shrinks Brain Tumors In Children With Tuberous Sclerosis Complex, Study Finds 25
Jul 08, 2011: Novartis’s Afinitor Meets Primary Endpoint Of Reducing SEGA Tumor Size In Patients With Tuberous Sclerosis In Phase III Study 25
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Novartis AG 28
Clinical Trial Overview of Novartis AG 28
Clinical Trial Overview of Top Institutes / Government 29
National Cancer Institute 29
Clinical Trial Overview of National Cancer Institute 29
Mayo Clinic 30
Clinical Trial Overview of Mayo Clinic 30
Cincinnati Children''s Hospital Medical Center 31
Clinical Trial Overview of Cincinnati Children''s Hospital Medical Center 31
Barbara Ann Karmanos Cancer Institute 32
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 32
Five Key Clinical Profiles 33

Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 120

List of Tables

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Subependymal Giant Cell Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Subependymal Giant Cell Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials, E7 Countries (%), 2014* 15
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Subependymal Giant Cell Astrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 23
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 28
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 29
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 30
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children''s Hospital Medical Center, 2014* 31
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014* 32

List of Figures

Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Subependymal Giant Cell Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Subependymal Giant Cell Astrocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Subependymal Giant Cell Astrocytoma to Oncology Clinical Trials, E7 Countries (%), 2014* 15
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Subependymal Giant Cell Astrocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Subependymal Giant Cell Astrocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
Subependymal Giant Cell Astrocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 118

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing